MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA

References

• Gonzalez-Marron A, Martin-Sanchez JC, Miro Q, et al. Relation between tobacco control policies and population at high risk of lung cancer in the European Union. Environ Res. 2019;179(Pt A):108594.
   PubMedGoogle Scholar
• Wei X, Shen X, Ren Y, et al. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer. Curr Pharm Des. 2018;23(39):5983–5988.
   PubMed Web of Science ®Google Scholar
• Szejniuk WM, Robles AI, McCulloch T, et al. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. Pharmacogenomics J. 2019;19(1):5–14.
   PubMed Web of Science ®Google Scholar
• Gong FY, Bai T, Zhang DY, et al. Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer. Curr Pharm Des. 2018;23(39):5973–5982.
   PubMed Web of Science ®Google Scholar
• Petrek H, Yu AM. MicroRNAs in non-small cell lung cancer: gene regulation, impact on cancer cellular processes, and therapeutic potential. Pharmacol Res Perspect. 2019;7(6):e00528.
   PubMed Web of Science ®Google Scholar
• Zhu B, Ren C, Du K, et al. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways. Biochem Pharmacol. 2019;170:113642.
   PubMed Web of Science ®Google Scholar
• Khandelwal A, Seam RK, Gupta M, et al. Circulating microRNA-590-5p acts as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci. 2019;111(3):826-839.
   Google Scholar
• Zanoaga O, Braicu C, Jurj A, et al. Progress in Research on the Role of Flavonoids in Lung Cancer. Int J Mol Sci. 2019;20(17):17.
   Web of Science ®Google Scholar
• Cha BK, Kim YS, Hwang KE, et al. Celecoxib and sulindac inhibit TGF-beta1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1. Oncotarget. 2016;7(35):57213–57227.
   PubMedGoogle Scholar
• Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11(2):136–146.
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466(7308):835–840.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9(1):287–314.
   PubMedGoogle Scholar
• Halvorsen AR, Ragle Aure M, Ojlert AK, et al. Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC. Mol Oncol. 2019;13(12):2604–2615.
   PubMed Web of Science ®Google Scholar
• Chen B, Gao T, Yuan W, et al. Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer. J Cancer. 2019;10(23):5793–5804.
   PubMed Web of Science ®Google Scholar
• Wang R, Chen X, Xu T, et al. MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR. Am J Cancer Res. 2016;6(2):173–186.
   PubMed Web of Science ®Google Scholar
• Li D, Du X, Liu A, et al. Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells. Oncol Rep. 2016;35(2):1117–1124.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu J, Xu J, et al. MiR-326/Sp1/KLF3: a novel regulatory axis in lung cancer progression. Cell Prolif. 2019;52(2):e12551.
   PubMed Web of Science ®Google Scholar
• Patra S, Panigrahi DP, Praharaj PP, et al. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy. Cell Mol Life Sci. 2019;76(17):3263–3282.
   PubMed Web of Science ®Google Scholar
• Xie M, Liu M, He CS. SIRT1 regulates endothelial Notch signaling in lung cancer. PLoS One. 2012;7(9):e45331.
   PubMed Web of Science ®Google Scholar
• Grbesa I, Pajares MJ, Martinez-Terroba E, et al. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients. PLoS One. 2015;10(4):e0124670.
   PubMed Web of Science ®Google Scholar
• Hosokawa H, Ungerback J, Wang X, et al. Transcription Factor PU.1 Represses and Activates Gene Expression in Early T Cells by Redirecting Partner Transcription Factor Binding. Immunity. 2018;49(4):782.
   PubMed Web of Science ®Google Scholar
• Yu Q, Dong L, Li Y, et al. SIRT1 and HIF1alpha signaling in metabolism and immune responses. Cancer Lett. 2018;418:20–26.
   PubMed Web of Science ®Google Scholar
• Wang Y, He J, Jiang H, et al. Nicotine enhances storeoperated calcium entry by upregulating HIF1alpha and SOCC components in nonsmall cell lung cancer cells. Oncol Rep. 2018;40(4):2097–2104.
   PubMed Web of Science ®Google Scholar
• Wei TT, Lin YT, Tang SP, et al. Metabolic targeting of HIF-1alpha potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer. Oncogene. 2020;39(2):414–427.
   PubMed Web of Science ®Google Scholar
• Yu W, Peng W, Sha H, et al. Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells. Oncol Res. 2019;27(5):623–628.
   PubMed Web of Science ®Google Scholar
• Yousafzai NA, Zhou Q, Xu W, et al. SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer. Cell Death Dis. 2019;10(5):363.
   PubMedGoogle Scholar
• Hong KS, Park JI, Kim MJ, et al. Involvement of SIRT1 in hypoxic down-regulation of c-Myc and beta-catenin and hypoxic preconditioning effect of polyphenols. Toxicol Appl Pharmacol. 2012;259(2):210–218.
   PubMed Web of Science ®Google Scholar
• Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418–2429.
   PubMed Web of Science ®Google Scholar
• Robinson D, Hawthorne S, Zhao L, et al. Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018. Future Oncol. 2020;16(7):255–262.
   PubMed Web of Science ®Google Scholar
• Tutar Y, Ozgur A, Tutar E, et al. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer. Biomed Pharmacother. 2016;83:1182–1190.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sui J, Shen X, et al. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Oncol Rep. 2017;37(6):3543–3553.
   PubMed Web of Science ®Google Scholar
• Sun C, Huang C, Li S, et al. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. Oncotarget. 2016;7(7):8341–8359.
   PubMedGoogle Scholar
• Yu W, Jiang H, Zhang H, et al. Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer. Onco Targets Ther. 2018;11:5569–5577.
   PubMed Web of Science ®Google Scholar
• Ryan ZC, Craig TA, Folmes CD, et al. 1alpha,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells. J Biol Chem. 2016;291(3):1514–1528.
   PubMed Web of Science ®Google Scholar
• Han L, Liang XH, Chen LX, et al. SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. Int J Clin Exp Pathol. 2013;6(11):2357–2365.
   PubMed Web of Science ®Google Scholar
• Chaiyawat P, Pruksakorn D, Phanphaisarn A, et al. Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications. Mod Pathol. 2018;31(2):264–274.
   PubMed Web of Science ®Google Scholar
• Noh SJ, Baek HA, Park HS, et al. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer. Pathol Res Pract. 2013;209(6):365–370.
   PubMed Web of Science ®Google Scholar
• Guan Y, Rao Z, Chen C. miR-30a suppresses lung cancer progression by targeting SIRT1. Oncotarget. 2018;9(4):4924–4934.
   PubMedGoogle Scholar
• Cheng P, Lu P, Guan J, et al. LncRNA KCNQ1OT1 controls cell proliferation, differentiation and apoptosis by sponging miR-326 to regulate c-Myc expression in acute myeloid leukemia. Neoplasma. 2020;67(2):238-248.
   Google Scholar
• Mo Y, He L, Lai Z, et al. Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2019;47(1):2830–2837.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Liang HL, Jin TE, et al. Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer. Int J Clin Exp Pathol. 2015;8(9):11278–11286.
   PubMed Web of Science ®Google Scholar
• Guan R, Lv J, Xiao F, et al. Potential role of the cAMP/PKA/CREB signalling pathway in hypoxic preconditioning and effect on propofolinduced neurotoxicity in the hippocampus of neonatal rats. Mol Med Rep. 2019;20(2):1837–1845.
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhen Y, Fu L, et al. Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells. Bioorg Med Chem Lett. 2019;29(19):126623.
   PubMed Web of Science ®Google Scholar
• Sone M, Toyoda T, Cho YM, et al. Immunohistochemistry of gamma-H2AX as a method of early detection of urinary bladder carcinogenicity in mice. J Appl Toxicol. 2019;39(6):868–876.
   PubMed Web of Science ®Google Scholar
• Xu C, Zhang L, Duan L, et al. MicroRNA-3196 is inhibited by H2AX phosphorylation and attenuates lung cancer cell apoptosis by downregulating PUMA. Oncotarget. 2016;7(47):77764–77776.
   PubMedGoogle Scholar
• Wang XL, Wu LY, Zhao L, et al. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis. Biomed Pharmacother. 2016;83:41–50.
   PubMed Web of Science ®Google Scholar
• Sikdar S, Datta S. A novel statistical approach for identification of the master regulator transcription factor. BMC Bioinformatics. 2017;18(1):79.
   PubMedGoogle Scholar
• Su T, Liu P, Ti X, et al. ΗΙF1α, EGR1 and SP1 co-regulate the erythropoietin receptor expression under hypoxia: an essential role in the growth of non-small cell lung cancer cells. Cell Commun Signal. 2019;17(1):152.
   PubMed Web of Science ®Google Scholar
• Joo HY, Yun M, Jeong J, et al. SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1alpha (HIF-1alpha) via direct interactions during hypoxia. Biochem Biophys Res Commun. 2015;462(4):294–300.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bernauer AM, Yingling CM, et al. HIF1alpha regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis. 2012;33(6):1187–1192.
   PubMed Web of Science ®Google Scholar
• Qin LXY, Feng Z, et al. Abstract 2694: SRC-1 promotes tumor angiogenesis through up-regulation of HIF1 -mediated VEGFa expression. Cancer Res. 2013;73(8 Supplement):2694.
   Google Scholar
• Yang Z, Wang H, Jiang Y, et al. VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis. Am J Pathol. 2014;184(4):1230–1239.
   PubMed Web of Science ®Google Scholar
• Chen CH, Lai JM, Chou TY, et al. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One. 2009;4(4):e5052.
   PubMed Web of Science ®Google Scholar
• Zhan S, Wang C, Yin F. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA. Mol Med Rep. 2018;17(5):6705–6710.
   PubMed Web of Science ®Google Scholar